Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
PharmiWeb
12h
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Projected to Reach USD 28 Billion by 2033 at a 9.5% of CAGR
Treatment MarketThe global castration-resistant prostate cancer (CRPC) treatment market is poised for substantial growth, ...
FiercePharma
14h
Fierce Pharma Asia—Astellas' first-in-class FDA nod; Otsuka's IgAN win; Samsung Bio's $1.2B contract
Astellas' first-in-class CLDN18.2 drug Vyloy has cleared the FDA. After a positive phase 3 readout, Otsuka is targeting an ...
pharmaphorum
18h
NICE backs two AIs for remote heart failure monitoring
Updated guidance from health technology assessment (HTA) agency NICE has concluded that Boston Scientific's HeartLogic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Grateful Dead bassist dies
DOJ reaches settlement
DNA tests identify skull
Kristy now Category 5
Apology for past US policy
ABC News icon Jarriel dies
Exonerated after 22 years
Hit w/ discrimination claims
4 astronauts return to Earth
Louisiana forces relocation
Browns sue city of Cleveland
AI firm sued over suicide
Murder-for-hire plot arrest
US mortgage rate climbs
Seeks Jan. 6 case dismissal
Strike kills 3 journalists
USF basketball coach dies
Madigan corruption trial
Recalls chicken products
MO AG to probe Google
CO ballots to be reexamined
E. coli infections rise to 75
Phones hacked by China?
SC teen voting glitch
Dismissal of charge upheld
Announces layoffs, jet sales
New student loan relief plan
Gaza peace talks to resume?
Won't endorse candidates
Approves Iterum's treatment
Israel strikes back at Iran
PA registration fraud probe
Related topics
Vyloy
United States
Food and Drug Administration
Feedback